Dinsmore Christopher's Form 4 filing
Kronos Bio, Inc. (KRON) · filed Dec 15, 2021
- Accession no.
- 0001209191-21-069783
- Filed
- Dec 15, 2021
- Trade date
- Dec 13, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $140.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dinsmore ChristopherCIK 0001826766 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2021 | Common Stock | SSaleDisposed | −11,212 | $12.36 | −$138,580.32 | 85,148 | Direct | |
| Dec 13, 2021 | Common Stock | SSaleDisposed | −174 | $12.82 | −$2,230.68 | 84,974 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.